MSLN and acute myeloid leukemia: Notably, the comparison of AML patients with a high percentage of mesothelin-positive cells to those with no mesothelin expression or <1% mesothelin-positive cells revealed significantly higher OCR in the mesothelin-high group (Figure 2A).